Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GP120' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1722 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Grant, MD
      Antibody convergence along a common idiotypic axis in immunodeficiency virus and hepatitis C virus infections

      JOURNAL OF MEDICAL VIROLOGY
    2. Xu, XN; Screaton, G
      HIV-1 Nef: negative effector of Fas?

      NATURE IMMUNOLOGY
    3. Crombie, R; Kawasaki, K; Hojo, K; Laurence, J
      Peptides derived from salivary thrombospondin-1 replicate its anti-HIV effect: Potential role in microbicide development

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Lemiale, F; Brand, D; Lebigot, S; Verrier, T; Buzelay, L; Brunet, S; Barin, F
      Immunogenicity of recombinant envelope glycoproteins derived from T-cell line-adapted isolates or primary HIV isolates - A comparative study using multivalent vaccine approaches

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Marone, G; Florio, G; Petraroli, A; Triggiani, M; de Paulis, A
      Human mast cells and basophils in HIV-1 infection

      TRENDS IN IMMUNOLOGY
    6. Winterfeld, GA; Schmidt, RR
      Nitroglycal concatenation: A broadly applicable and efficient approach to the synthesis of complex O-glycans

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    7. Gu, YM; LaBell, R; O'Brien, DF; Saavedra, SS
      Quantitative studies of binding between synthetic galactosyl ceramide analogues and HIV-1 Gp120 at planar membrane surfaces

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    8. Li, C; Dowd, CS; Zhang, W; Chaiken, IM
      Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences

      JOURNAL OF PEPTIDE RESEARCH
    9. Dowd, CS; Zhang, WT; Li, CZ; Chaiken, IM
      From receptor recognition mechanisms to bioinspired mimetic antagonists inHIV-1/cell docking

      JOURNAL OF CHROMATOGRAPHY B
    10. Turville, SG; Cameron, PU; Arthos, J; MacDonald, K; Clark, G; Hart, D; Cunningham, AL
      Bitter-sweet symphony: defining the role of dendritic cell gp120 receptorsin HIV infection

      JOURNAL OF CLINICAL VIROLOGY
    11. Schweighardt, B; Atwood, WJ
      Virus receptors in the human central nervous system

      JOURNAL OF NEUROVIROLOGY
    12. Stins, MF; Shen, Y; Huang, SH; Gilles, F; Kalra, VK; Kim, KS
      Gp120 activates children's brain endothelial cells via CD4

      JOURNAL OF NEUROVIROLOGY
    13. Cadet, P; Weeks, BS; Bilfinger, TV; Mantione, KJ; Casares, F; Stefano, GB
      HIV gp120 and morphine alter mu opiate receptor expression in human vascular endothelium

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    14. Bezzi, P; Domercq, M; Brambilla, L; Galli, R; Schols, D; De Clercq, E; Vescovi, A; Bagetta, G; Kollias, G; Meldolesi, J; Volterra, A
      CXCR4-activated astrocyte glutamate release via TNFa: amplification by microglia triggers neurotoxicity

      NATURE NEUROSCIENCE
    15. Overbaugh, J; Miller, AD; Eiden, MV
      Receptors and entry cofactors for retroviruses include single and multipletransmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins

      MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
    16. Su, J; Andersson, E; Horai, P; Naghavi, MH; Palm, A; Wu, YP; Eriksson, K; Jansson, M; Wigzell, H; Svennerholm, B; Vahlne, A
      The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1

      JOURNAL OF HUMAN VIROLOGY
    17. Su, J; Naghavi, MH; Jejcic, A; Horal, P; Furuta, Y; Wu, YP; Li, SL; Hall, WW; Goobar-Larsson, L; Svennerholm, B; Vahlne, A
      The tripeptide glycyl-prolyl-glycine amide does not affect the early stepsof the human immunodeficiency virus type 1 replication

      JOURNAL OF HUMAN VIROLOGY
    18. Chen, XN; Scala, G; Quinto, I; Liu, WM; Chun, TW; Justement, JS; Cohen, OJ; vanCott, TC; Iwanicki, M; Lewis, MG; Greenhouse, J; Barry, T; Venzon, D; Fauci, AS
      Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes

      NATURE MEDICINE
    19. Saha, K; Zhang, JC; Gupta, A; Dave, R; Yimen, M; Zerhouni, B
      Isolation of primary HIV-1 that target CD8(+) T Lymphocytes using CD8 as areceptor

      NATURE MEDICINE
    20. Ozyoruk, F; Cheevers, WP; Hullinger, GA; McGuire, TC; Hutton, M; Knowles, DP
      Monoclonal antibodies to conformational epitopes of the surface glycoprotein of caprine arthritis-encephalitis virus: Potential application to competitive-inhibition enzyme-linked immunosorbent assay for detecting antibodiesin goat sera

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    21. Kenakin, TP
      Quantitation in receptor pharmacology

      RECEPTORS & CHANNELS
    22. Piguet, V; Trono, D
      Living in oblivion: HIV immune evasion

      SEMINARS IN IMMUNOLOGY
    23. Eniade, A; Murphy, AV; Landreau, G; Ben, RN
      A general synthesis of structurally diverse building blocks for preparing analogues of C-linked antifreeze glycoproteins

      BIOCONJUGATE CHEMISTRY
    24. Ikeda, K; Konishi, K; Sato, M; Hoshino, H; Tanaka, K
      Inhibition of HIV-1 infection by synthetic peptide analogues derived from the NH2-terminal extracellular region of GPR1

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    25. Polzer, S; Dittmar, MT; Schmitz, H; Meyer, B; Muller, H; Krausslich, HG; Schreiber, M
      Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1

      GLYCOBIOLOGY
    26. Patton, HK; Chu, WJ; Hetherington, HP; den Hollander, J; Stewart, KE; Raper, JL; Shelton, BJ; Benveniste, EN; Benos, DJ
      Alkaline pH changes in the cerebellum of asymptomatic HIV-infected individuals

      NMR IN BIOMEDICINE
    27. Caffrey, M
      Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    28. Patterson, LJ; Robey, F; Muck, A; Van Remoortere, K; Aldrich, K; Richardson, E; Alvord, WG; Markham, PD; Cranage, M; Robert-Guroff, M
      A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    29. Kanbara, K; Sato, S; Tanuma, J; Tamamura, H; Gotoh, K; Yoshimori, M; Kanamoto, T; Kitano, M; Fujii, N; Nakashima, H
      Biological and genetic characterization of a human immunodeficiency virus strain resistant to CXCR4 antagonist t134

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    30. Robey, FA; Robert-Guroff, M
      A defined conformational epitope from the C4 domain of HIV type 1 glycoprotein 120: Anti-cyclic C4 antibodies from HIV-positive donors magnify glycoprotein 120 suppression of interleukin 2 produced by T cells

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    31. Daniel, V; Susal, C; Weimer, R; Zimmermann, R; Huth-Kuhne, A; Opelz, G
      Increased soluble Fas in HIV-infected hemophilia patients with CD4(+) and CD8(+) cell count increases and viral load and immune complex decreases

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    32. Zhang, YJ; Zhang, LQ; Ketas, T; Korber, BTM; Moore, JP
      HIV type 1 molecular clones able to use the Bonzo/STRL-33 coreceptor for virus entry

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    33. Parekh, BS; Pau, CP; Kennedy, MS; Dobbs, TL; McDougal, JS
      Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    34. Patterson, S; English, NR; Longhurst, H; Jain, P; Balfe, P; Knight, SC
      Relationship between V3 sequences of HIV type 1 from plasma, T cells, and dendritic cells suggests that plasma virus may arise from different cell sources

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    35. Li, Y; Rey-Cuille, MA; Hu, SL
      N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    36. Jansson, M; Backstrom, E; Scarlatti, G; Bjorndal, A; Matsuda, S; Rossi, P; Albert, J; Wigzell, H
      Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    37. D'Costa, S; Slobod, KS; Webster, RG; White, SW; Hurwitz, JL
      Structural features of HIV envelope defined by antibody escape mutant analysis

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    38. Losman, B; Bolmstedt, A; Schonning, K; Bjorndal, A; Westin, C; Fenyo, EM; Olofsson, S
      Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type I glycoprotein 120 by N-linked oligosaccharides in the V1 region

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    39. Gomez, CE; Iglesias, E; Perdomo, W; Rolo, F; Blanco, M; Lobaina, L; Martin, A; Duarte, CA
      Isolates from four different HIV type 1 clades circulating in Cuba identified by DNA sequence of the C2-V3 region

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    40. Jagodzinski, PP; Trzeciak, WH
      Additive effect of tunicamycin and dextran sulfate on the binding of monoclonal antibody to the V2 domain of the envelope glycoprotein 120 of human immunodeficiency virus type 1

      BIOMEDICINE & PHARMACOTHERAPY
    41. Poignard, P; Saphire, EO; Parren, PWHI; Burton, DR
      GP120: Biologic aspects of structural features

      ANNUAL REVIEW OF IMMUNOLOGY
    42. Sorbera, LA; Leeson, PA; Castaner, J
      CPI-1189 - Treatment of AIDS dementia antiparkinsonian treatment of Alzheimer's dementia

      DRUGS OF THE FUTURE
    43. Navarra, M; Romano, C; Lorenzon, T; Rotiroti, D; Di Renzo, GR
      Ethanol exposure inhibits the cytotoxic effect induced by gp120 in CHP100 human neuroblastoma cells

      JOURNAL OF NEUROSCIENCE RESEARCH
    44. Begovac, J; Lepej, SZ; Kniewald, T; Lisic, M
      Biological, epidemiological and clinical basis of understanding human immunodeficiency virus infection

      COLLEGIUM ANTROPOLOGICUM
    45. Viviani, B; Corsini, E; Binaglia, M; Galli, CL; Marinovich, M
      Reactive oxygen species generated by glia are responsible for neuron deathinduced by human immunodeficiency virus-glycoprotein 120 in vitro

      NEUROSCIENCE
    46. Belmadani, A; Zou, JY; Schipma, MJ; Neafsey, EJ; Collins, MA
      Ethanol pre-exposure suppresses HIV-1 glycoprotein 120-induced neuronal degeneration by abrogating endogenous glutamate/Ca2+-mediated neurotoxicity

      NEUROSCIENCE
    47. Roger, PM; Breittmayer, JP; Cottalorda, J; Ticchioni, M; Mondain, V; Dellamonica, P; Bernard, A
      Persistent viral load in patients on HAART is associated with a higher level of activation-induced apoptosis of CD4(+) T cells

      Journal of antimicrobial chemotherapy
    48. Corasaniti, MT; Piccirilli, S; Paoletti, A; Nistico, R; Stringaro, A; Malorni, W; Finazzi-Agro, A; Bagetta, G
      Evidence that the HIV-1 coat protein gp120 causes neuronal apoptosis in the neocortex of rat via a mechanism involving CXCR4 chemokine receptor

      NEUROSCIENCE LETTERS
    49. Muller, S; Margolin, DH; Min, G; Lou, D; Nara, P; Axthelm, MK; Kohler, H
      Stimulation of antiviral antibody response in SHIV-IIIB-infected macaques

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    50. Jason, J; Inge, KL
      Modulation of CD8 and CD3 by HIV or HIV antigens

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    51. Oh, SB; Tran, PB; Gillard, SE; Hurley, RW; Hammond, DL; Miller, RJ
      Chemokines and glycoprotein 120 produce pain hypersensitivity by directly exciting primary nociceptive neurons

      JOURNAL OF NEUROSCIENCE
    52. Lee, SA; Orque, R; Escarpe, PA; Peterson, ML; Good, JW; Zaharias, EM; Berman, PW; Sheppard, HW; Shibata, R
      Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates

      VACCINE
    53. Toledo, H; Baly, A; Castro, O; Resik, S; Laferte, J; Rolo, F; Navea, L; Lobaina, L; Cruz, O; Miguez, J; Serrano, T; Sierra, B; Perez, L; Ricardo, ME; Dubed, M; Lubian, AL; Blanco, M; Millan, JC; Ortega, A; Iglesias, E; Penton, E; Martin, Z; Perez, J; Diaz, M; Duarte, CA
      A phase I clinical trial of a mufti-epitope polypeptide TAB9 combined withMontanide ISA 720 adjuvant in non-HIV-1 infected human volunteers

      VACCINE
    54. Klein, M
      Current progress in the development of human immunodeficiency virus vaccines: research and clinical trials

      VACCINE
    55. Veljkovic, V; Metlas, R; Kohler, H; Urnovitz, HB; Prljic, J; Veljkovic, N; Johnson, E; Muller, S
      AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategy

      VACCINE
    56. Evans, TG; McElrath, MJ; Matthews, T; Montefiori, D; Weinhold, K; Wolff, M; Keefer, MC; Kallas, EG; Corey, L; Gorse, GJ; Belshe, R; Graham, BS; Spearman, PW; Schwartz, D; Mulligan, MJ; Goepfert, P; Fast, P; Berman, P; Powell, M; Francis, D
      QS-21 promotes an adjuvant effect allowing for reduced antigen dose duringHIV-1 envelope subunit immmunization in humans

      VACCINE
    57. Rehm, A; Stern, P; Ploegh, HL; Tortorella, D
      Signal peptide cleavage of a type I membrane protein, HCMV US11, is dependent on its membrane anchor

      EMBO JOURNAL
    58. Chen, MS; Shi, CF; Kalia, V; Tencza, SB; Montelaro, RC; Gupta, P
      HIV gp120 V-1/V-2 andC(2)-V-3 domains glycoprotein compatibility is required for viral replication

      VIRUS RESEARCH
    59. Ruff, MR; Melendez-Guerrero, LM; Yang, QE; Ho, WZ; Mikovits, JW; Pert, CB; Ruscetti, FA
      Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5)

      ANTIVIRAL RESEARCH
    60. LaBranche, CC; Galasso, G; Moore, JP; Bolognesi, DP; Hirsch, MS; Hammer, SM
      HIV fusion and its inhibition

      ANTIVIRAL RESEARCH
    61. Power, C
      Retroviral diseases of the nervous system: pathogenic host response or viral gene-mediated neurovirulence?

      TRENDS IN NEUROSCIENCES
    62. Joliot, V; Goujon, C; Dumonceaux, J; Renard, A; Briand, P; Hazan, U
      A human immunodeficiency virus Env inducible transcription system to examine consequences of gp120 expression

      JOURNAL OF VIROLOGICAL METHODS
    63. Pozzoli, G; Tringali, G; Dello Russo, C; Vairano, M; Preziosi, P; Navarra, P
      HIV-1 gp120 protein modulates corticotropin releasing factor synthesis andrelease via the stimulation of its mRNA from the rat hypothalamus in vitro: involvement of inducible nitric oxide synthase

      JOURNAL OF NEUROIMMUNOLOGY
    64. Jeffs, SA; Gorny, MK; Williams, C; Revesz, K; Volsky, B; Burda, S; Wang, XH; Bandres, J; Zolla-Pazner, S; Holmes, H
      Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120

      IMMUNOLOGY LETTERS
    65. Daniel, V; Susal, C; Weimer, R; Zimmermann, R; Huth-Kuhne, A; Opelz, G
      Association of immune complexes and plasma viral load with CD4(+) cell depletion, CD8(+)DR(+) and CD16(+) cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4(+) lymphocyte depletion

      IMMUNOLOGY LETTERS
    66. Singh, SB; Jayasuriya, H; Salituro, GM; Zink, DL; Shafiee, A; Heimbuch, B; Silverman, KC; Lingham, RB; Genilloud, O; Teran, A; Vilella, D; Felock, P; Hazuda, D
      The complestatins as HIV-1 integrase inhibitors. Efficient isolation, structure elucidation, and inhibitory activities of isocomplestatin, chloropeptin I, new complestatins, A and B, and acid-hydrolysis products of chloropeptin I

      JOURNAL OF NATURAL PRODUCTS
    67. Pugh, CR; Fleshner, M; Watkins, LR; Maier, SF; Rudy, JW
      The immune system and memory consolidation: a role for the cytokine IL-1 beta

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    68. Ondoa, P; Davis, D; Willems, B; Heyndrickx, L; Kestens, L; van der Berg, I; Coppens, S; Janssens, W; Heeney, J; van der Groen, G
      Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally

      JOURNAL OF MEDICAL VIROLOGY
    69. Annicchiarico-Petruzzelli, M; Bernassola, F; Lovat, PE; Redfern, CPF; Pearson, ADJ; Melino, G
      Apoptosis in neuroblastomas induced by interferon-gamma involves the CD95/CD95L pathway

      MEDICAL AND PEDIATRIC ONCOLOGY
    70. Eckert, DM; Kim, PS
      Mechanisms of viral membrane fusion and its inhibition

      ANNUAL REVIEW OF BIOCHEMISTRY
    71. Portis, JL
      Genetic determinants of neurovirulence of murine oncornaviruses

      ADVANCES IN VIRUS RESEARCH, VOL 56
    72. Power, C; Johnson, RT
      Neuroimmune and neurovirological aspects of human immunodeficiency virus infection

      ADVANCES IN VIRUS RESEARCH, VOL 56
    73. Barry, JD; McCulloch, R
      Antigenic variation in trypanosomes: Enhanced phenotypic variation in a eukaryotic parasite

      ADVANCES IN PARASITOLOGY, VOL 49
    74. Cole, KS; Alvarez, M; Elliott, DH; Lam, H; Martin, E; Chau, T; Micken, K; Rowles, JL; Clements, JE; Murphey-Corb, M; Montelaro, RC; Robinson, JE
      Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain

      VIROLOGY
    75. Aarons, EJ; Beddows, S; Willingham, T; Wu, LJ; Koup, RA
      Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7

      VIROLOGY
    76. Yao, QZ; Compans, RW; Chen, CY
      HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis

      VIROLOGY
    77. Frost, SDW; Gunthard, HF; Wong, JK; Havlir, D; Richman, DD; Brown, AJL
      Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy

      VIROLOGY
    78. Beirnaert, E; De Zutter, S; Janssens, W; van der Groen, G
      Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells

      VIROLOGY
    79. Kannan, A; De Clercq, E; Pannecouque, C; Witvrouw, M; Hartman, TL; Turpin, JA; Buckheit, RW; Cushman, M
      Synthesis and anti-HIV activity of a bile acid analog of cosalane

      TETRAHEDRON
    80. Saphire, EO; Parren, PWHI; Pantophlet, R; Zwick, MB; Morris, GM; Rudd, PM; Dwek, RA; Stanfield, RL; Burton, DR; Wilson, IA
      Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design

      SCIENCE
    81. Ferrarese, C; Aliprandi, A; Tremolizzo, L; Stanzani, L; De Micheli, A; Dolara, A; Frattola, L
      Increased glutamate in CSF and plasma of patients with HIV dementia

      NEUROLOGY
    82. Strizki, JM; Xu, S; Wagner, NE; Wojcik, L; Liu, J; Hou, Y; Endres, M; Palani, A; Shapiro, S; Clader, JW; Greenlee, WJ; Tagat, JR; McCombie, S; Cox, K; Fawzi, AB; Chou, CC; Pugliese-Sivo, C; Davies, L; Moreno, ME; Ho, DD; Trkola, A; Stoddart, CA; Moore, JP; Reyes, GR; Baroudy, BM
      SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    83. Wang, JH; Meijers, R; Xiong, Y; Liu, JH; Sakihama, T; Zhang, RG; Joachimiak, A; Reinherz, EL
      Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    84. Bolmstedt, AJ; O'Keefe, BR; Shenoy, SR; Mcmahon, JB; Boyd, MR
      HIV-inhibitory natural products part 71 - Cyanovirin-N defines a new classof antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner

      MOLECULAR PHARMACOLOGY
    85. Mori, K; Yasutomi, Y; Ohgimoto, S; Nakasone, T; Takamura, S; Shioda, T; Nagai, Y
      Quintuple deglycosylation mutant of simian immunodeficiency virus SIVmac239 in rhesus macaques: Robust primary replication, tightly contained chronicinfection, and elicitation of potent immunity against the parental wild-type strain

      JOURNAL OF VIROLOGY
    86. Letvin, NL; Robinson, S; Rohne, D; Axthelm, MK; Fanton, JW; Bilska, M; Palker, TJ; Liao, HX; Haynes, BF; Montefiori, DC
      Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and controlof a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope

      JOURNAL OF VIROLOGY
    87. Martin, J; LaBranche, CC; Gonzalez-Scarano, F
      Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate

      JOURNAL OF VIROLOGY
    88. Singer, II; Scott, S; Kawka, DW; Chin, J; Daugherty, BL; DeMartino, JA; DiSalvo, J; Gould, SL; Lineberger, JE; Malkowitz, L; Miller, MD; Mitnaul, L; Siciliano, SJ; Staruch, MJ; Williams, HR; Zweerink, HJ; Springer, MS
      CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells

      JOURNAL OF VIROLOGY
    89. Means, RE; Matthews, T; Hoxie, JA; Malim, MH; Kodama, T; Desrosiers, RC
      Ability of the v3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: Correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4

      JOURNAL OF VIROLOGY
    90. Kolchinsky, P; Kiprilov, E; Bartley, P; Rubinstein, R; Sodroski, J
      Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops

      JOURNAL OF VIROLOGY
    91. York, J; Follis, KE; Trahey, M; Nyambi, PN; Zolla-Pazner, S; Nunberg, JH
      Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1

      JOURNAL OF VIROLOGY
    92. Peterson, KE; Robertson, SJ; Portis, JL; Chesebro, B
      Differences in cytokine and chemokine responses during neurological disease induced by polytropic murine retroviruses map to separate regions of the viral envelope gene

      JOURNAL OF VIROLOGY
    93. Kolchinsky, P; Kiprilov, E; Sodroski, J
      Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants

      JOURNAL OF VIROLOGY
    94. Cho, MW; Kim, YB; Lee, MK; Gupta, KC; Ross, W; Plishka, R; Buckler-White, A; Igarashi, T; Theodore, T; Byrum, R; Kemp, C; Montefiori, DC; Martin, MA
      Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques

      JOURNAL OF VIROLOGY
    95. Spenlehauer, C; Kirn, A; Aubertin, AM; Moog, C
      Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: Investigation of the mechanism of inhibition

      JOURNAL OF VIROLOGY
    96. Beaumont, T; van Nuenen, A; Broersen, S; Blattner, WA; Lukashov, VV; Schuitemaker, H
      Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course

      JOURNAL OF VIROLOGY
    97. Broussard, SR; Staprans, SI; White, R; Whitehead, EM; Feinberg, MB; Allan, JS
      Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease

      JOURNAL OF VIROLOGY
    98. Esser, MT; Bess, JW; Suryanarayana, K; Chertova, E; Marti, D; Carrington, M; Arthur, LO; Lifson, JD
      Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1

      JOURNAL OF VIROLOGY
    99. Yang, XZ; Wyatt, R; Sodroski, J
      Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers

      JOURNAL OF VIROLOGY
    100. Pontow, S; Ratner, L
      Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors

      JOURNAL OF VIROLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 19:16:43